Helena Laboratories Corp (Helena) is a medical device company that provides clinical laboratory instruments. The company offers electrophoresis analyzers, densitometers, electrophoresis supplies, hemostasis instruments, spife replacement pumps, and immunology and protein diagnostic products. It offers column chromatography supplies, disposable laboratory plasticware and test kits for fecal occult blood. Helena offers automated gel electrophoresis systems for serum proteins, immunofixation, and cholesterol and hemoglobin analysis. The company caters to medical centers, hospitals, reference laboratories and private doctor's laboratories. It markets its products across Algeria, Argentina, Austria, Bahrain, Bangladesh, Belgium, Brazil, China, Colombia and Costa Rica. Helena is headquartered in Beaumont, Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Helena Laboratories Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Helena Laboratories Corp Company Overview
- Helena Laboratories Corp Company Snapshot
- Helena Laboratories Corp Pipeline Products and Ongoing Clinical Trials Overview
- Helena Laboratories Corp - Pipeline Analysis Overview
- Helena Laboratories Corp - Key Facts
- Helena Laboratories Corp - Major Products and Services
- Helena Laboratories Corp Pipeline Products by Development Stage
- Helena Laboratories Corp Pipeline Products Overview
- Actalyke Mini II - APTT Test
- Actalyke Mini II - APTT Test Product Overview
- Actalyke Mini II - LMWH Test
- Actalyke Mini II - LMWH Test Product Overview
- Actalyke Mini II - PT Test
- Actalyke Mini II - PT Test Product Overview
- Actalyke XL - APTT Test
- Actalyke XL - APTT Test Product Overview
- Actalyke XL - Heparin Test
- Actalyke XL - Heparin Test Product Overview
- Actalyke XL - LMWH Test
- Actalyke XL - LMWH Test Product Overview
- Actalyke XL - PT Test
- Actalyke XL - PT Test Product Overview
- AggRAM - Chromogenic Test
- AggRAM - Chromogenic Test Product Overview
- AggRAM - HIT Test
- AggRAM - HIT Test Product Overview
- AggRAM - Lumi Test
- AggRAM - Lumi Test Product Overview
- Cascade Abrazo - c-ACT-LR
- Cascade Abrazo - c-ACT-LR Product Overview
- Cascade Abrazo - Direct Oral Anticoagulants Test
- Cascade Abrazo - Direct Oral Anticoagulants Test Product Overview
- Cascade Abrazo - Direct Thrombin Inhibitors
- Cascade Abrazo - Direct Thrombin Inhibitors Product Overview
- Cascade Abrazo - Fibrinogen
- Cascade Abrazo - Fibrinogen Product Overview
- Cascade Abrazo - Heparin Titration
- Cascade Abrazo - Heparin Titration Product Overview
- Cascade Abrazo - LMWH
- Cascade Abrazo - LMWH Product Overview
- Cascade Abrazo - Protamine Titration
- Cascade Abrazo - Protamine Titration Product Overview
- Cascade Abrazo - PT-C
- Cascade Abrazo - PT-C Product Overview
- Cascade Abrazo Analyzer
- Cascade Abrazo Analyzer Product Overview
- Cascade M - DRVVT Test
- Cascade M - DRVVT Test Product Overview
- Cascade M-4 - DRVVT Test
- Cascade M-4 - DRVVT Test Product Overview
- Helena Laboratories Corp - Key Competitors
- Helena Laboratories Corp - Key Employees
- Helena Laboratories Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Helena Laboratories Corp, Recent Developments
- Oct 26, 2022: Helena Laboratories obtains CLIA clearance for the SPIFE A1AT Kit
- Oct 20, 2022: Helena Laboratories receives 510(k) clearance for SPIFE A1AT Kit
- Apr 26, 2022: Helena Laboratories receives 510(k) clearance for V8 Nexus Hemoglobin Ultrascreen
- Apr 25, 2022: Helena Laboratories receives 510(k) clearance for V8 AFSA2 Hemo Control
- Oct 22, 2021: Labcon awarded $59.3 million U.S Government contract to increase domestic production of pipette tips and tubes
- Nov 18, 2019: Labcon's ACT-labeled products set new standard for environmentally-friendly laboratory consumables
- May 16, 2017: Helena Biosciences to develop automated blood test for chronic liver disease based on VIB and Ghent University research
- Oct 27, 2015: Simple blood test measures risk of liver cancer
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Helena Laboratories Corp Pipeline Products and Ongoing Clinical Trials Overview
- Helena Laboratories Corp Pipeline Products by Equipment Type
- Helena Laboratories Corp Pipeline Products by Indication
- Helena Laboratories Corp, Key Facts
- Helena Laboratories Corp, Major Products and Services
- Helena Laboratories Corp Number of Pipeline Products by Development Stage
- Helena Laboratories Corp Pipeline Products Summary by Development Stage
- Actalyke Mini II - APTT Test - Product Status
- Actalyke Mini II - APTT Test - Product Description
- Actalyke Mini II - LMWH Test - Product Status
- Actalyke Mini II - LMWH Test - Product Description
- Actalyke Mini II - PT Test - Product Status
- Actalyke Mini II - PT Test - Product Description
- Actalyke XL - APTT Test - Product Status
- Actalyke XL - APTT Test - Product Description
- Actalyke XL - Heparin Test - Product Status
- Actalyke XL - Heparin Test - Product Description
- Actalyke XL - LMWH Test - Product Status
- Actalyke XL - LMWH Test - Product Description
- Actalyke XL - PT Test - Product Status
- Actalyke XL - PT Test - Product Description
- AggRAM - Chromogenic Test - Product Status
- AggRAM - Chromogenic Test - Product Description
- AggRAM - HIT Test - Product Status
- AggRAM - HIT Test - Product Description
- AggRAM - Lumi Test - Product Status
- AggRAM - Lumi Test - Product Description
- Cascade Abrazo - c-ACT-LR - Product Status
- Cascade Abrazo - c-ACT-LR - Product Description
- Cascade Abrazo - Direct Oral Anticoagulants Test - Product Status
- Cascade Abrazo - Direct Oral Anticoagulants Test - Product Description
- Cascade Abrazo - Direct Thrombin Inhibitors - Product Status
- Cascade Abrazo - Direct Thrombin Inhibitors - Product Description
- Cascade Abrazo - Fibrinogen - Product Status
- Cascade Abrazo - Fibrinogen - Product Description
- Cascade Abrazo - Heparin Titration - Product Status
- Cascade Abrazo - Heparin Titration - Product Description
- Cascade Abrazo - LMWH - Product Status
- Cascade Abrazo - LMWH - Product Description
- Cascade Abrazo - Protamine Titration - Product Status
- Cascade Abrazo - Protamine Titration - Product Description
- Cascade Abrazo - PT-C - Product Status
- Cascade Abrazo - PT-C - Product Description
- Cascade Abrazo Analyzer - Product Status
- Cascade Abrazo Analyzer - Product Description
- Cascade M - DRVVT Test - Product Status
- Cascade M - DRVVT Test - Product Description
- Cascade M-4 - DRVVT Test - Product Status
- Cascade M-4 - DRVVT Test - Product Description
- Helena Laboratories Corp, Key Employees
- Helena Laboratories Corp, Subsidiaries
- Glossary
- Helena Laboratories Corp Pipeline Products by Equipment Type
- Helena Laboratories Corp Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Point of Care Inc
- Gryphus Diagnostics LLC
- Diagnostica Stago Inc
- Aeron Lifecycles Clinical Laboratory
- Bio/Data Corp
